1. |
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002, 347(16): 1233-1241.
|
2. |
Narendra H, Ray S. Breast conserving surgery for breast cancer: single institutional experience from Southern India[J]. Indian J Cancer, 2012, 48(4): 415-422.
|
3. |
Emmadi R, Wiley EL. Evaluation of resection margins in breast conservation therapy: the pathology perspective-past, present, and future[J]. 2012, 2012: Article ID 180259, 9 pages. doi. org/10. 1155/2012/180259.
|
4. |
周韬, 黄平, 莫军扬, 等.早中期乳腺癌保留乳头乳晕改良根治术后离断背阔肌止点扩大肌皮瓣Ⅰ期乳房再造术的临床效果[J].中国普外基础与临床杂志, 2014, 21(2): 212-216.
|
5. |
Zhao S, Yang H, Zhang M, et al. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients[J]. Cell Biochem Biophys, 2013, 65(2): 263-273.
|
6. |
吴国球, 张臣, 孙宏伟, 等.建立人乳腺珠蛋白mRNA FQ-PCR方法用于乳腺癌微小转移的诊断[J].临床检验杂志, 2006, 24(2): 85-88.
|
7. |
Han JH, Kang Y, Shin HC, et al. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma[J]. Arch Pathol Lab Med, 2003, 127(10): 1330-1334.
|
8. |
Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer[J]. Cancer Res, 1996, 56(4): 860-865.
|
9. |
Zuo L, Li L, Wang Q, et al. Mammaglobin as a potential molecular target for breast cancer drug delivery[J]. Cancer Cell Int, 2009, 9: 8.
|
10. |
Lee GW, Kim JY, Koh EH, et al. Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer[J]. Genet Mol Res, 2012, 11(4): 4034-4042.
|
11. |
葛旭明, 高方喜, 陈昊.乳腺癌皮肤浸润及其临床相关因素[J].医学理论与实践, 2001, 14(6): 495-497.
|
12. |
Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients[J]. J Am Acad Dermatol, 1990, 22(1): 19-26.
|
13. |
Ho CM, Mak CK, Lau Y, et al. Skin involvement in invasive breast carcinoma: safety of skin-sparing mastectomy[J]. Ann Surg Oncol, 2003, 10(2): 102-107.
|
14. |
Chiummariello S, Arleo S, Pataia E, et al. Skin reducing mastectomy and immediate breast reconstruction with Becker 35 contour profile breast implant: our experience[J]. Minerva Chir, 2012, 67(1): 59-66.
|
15. |
Kim SI, Cho SH, Lee JS, et al. Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes[J]. Br J Cancer, 2013, 109(5): 1165-1171.
|
16. |
Huang L, Liu Z, Chen S, et al. A prognostic model for triplenegative breast cancer patients based on node status, cathepsin-D and Ki-67 index[J]. PLoS One, 2013, 8(12): e83081.
|
17. |
Elkhodary TR, Ebrahim MA, Hatata EE, et al. Prognostic value of lymph node ratio in node-positive breast cancer in Egyptian patients[J]. J Egypt Natl Canc Inst, 2014, 26(1): 31-35.
|
18. |
Pirozzi PR, Rossetti C, Carelli I, et al. Clinical and morphological factors predictive of occult involvement of the nipple-areola complex in mastectomy specimens[J]. Eur J Obstet Gynecol Reprod Biol, 2010, 148(2): 177-181.
|